Senna 7.5mg tablets

Country: Ingilterra

Lingwa: Ingliż

Sors: MHRA (Medicines & Healthcare Products Regulatory Agency)

Ingredjent attiv:

Senna fruit

Disponibbli minn:

Healthcare Pharma Ltd

Kodiċi ATC:

A06AB06

INN (Isem Internazzjonali):

Senna fruit

Dożaġġ:

7.5mg

Għamla farmaċewtika:

Oral tablet

Klassi:

No Controlled Drug Status

Tip ta 'preskrizzjoni:

Valid as a prescribable product

Sommarju tal-prodott:

BNF: 01060200; GTIN: 5060013770203 5060013770609

Karatteristiċi tal-prodott

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Boots Senna Adult Laxative 7.5 mg Tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains Alexandrian Senna fruit (_Cassia senna _ L. (_C.
acutifolia _
Delile)
fruit)
corresponding
to
7.5
mg
hydroxyanthracene
glycosides,
calculated as sennoside B
3
PHARMACEUTICAL FORM
Tablet
A plain greenish-brown round tablet
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
For short term relief of occasional constipation.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
For oral use only.
Adults and the elderly: 1 to 2 tablets to be taken at bedtime.
Should not be used in children or adolescents under the age of 18
years.
The maximum daily dose of hydroxyanthracene glycosides is 15 mg. This
is
equivalent to 2 tablets. The correct individual dose is the smallest
required to
produce a comfortable soft-formed motion.
The dose should be decreased as the bowel habit becomes regular.
Duration of use
Not to be used for more than 1 week. Usually it is sufficient to take
this
medicinal product up to two to three times during that week.
If there is no bowel movement after three days a doctor should be
consulted.
If the symptoms persist during the use of the medicinal product, a
doctor or a
pharmacist should be consulted.
See also section 4.4 Special warnings and precautions for use.
4.3
CONTRAINDICATIONS
Hypersensitivity to any of the ingredients.
Cases of intestinal obstructions and stenosis, atony, appendicitis,
inflammatory
colon diseases (e.g. Crohn’s disease, ulcerative colitis) abdominal
pain of
unknown origin, severe dehydration state with water and electrolyte
depletion.
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Do not exceed the stated dose.
Should not be used in children or adolescents under the age of 18
years.
Long-term use of stimulant laxatives should be avoided, as use for
more than a
brief period of treatment may lead to impaired function of the
intestine and
dependence on laxatives. If laxatives are needed every day the cause
of the
consti